A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome

Blood

Volumn 108, Issue 4, 2006, Pages 1306-1312

  Del Rey, Manuel ^b   Ruiz Contreras, Jesus ^b   Bosque, Alberto ^b   Calleja, Sara ^b   Gomez Rial, Jose ^b   Roldan, Ernesto ^b   Morales, Pablo ^b   Serrano, Antonio ^b   Anel, Alberto ^b   Paz Artal, Estela ^b   Allende, Luis M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL DEATH; CELL STRAIN COS1; CLINICAL FEATURE; CYTOTOXICITY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSFECTION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCHOOL CHILD; T LYMPHOCYTE;

EID: 33747195012     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-04-015776     Document Type: Article

References (34)

1. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol. 1994;6:1567-1574.
2. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449-1456.
3. Golstein P. FasL binds preassembled Fas. Science. 2000;288:2328-2329.
4. Krueger A, Fas SC, Baumann S, Krammer PH. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev. 2003;193:58-69.
5. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243-269.
6. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder explained by defects in Fas antigen that mediates apoptosis. Nature. 1995;356:314-317.
7. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994;76:969-976.
8. Canale VC, Smith CH. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr. 1967;70:891-899.
9. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935-946.
10. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268:1347-1349.
11. Sneller MC, Dale JK, Straus SE. Autoimmune lymphoproliferative syndrome. Curr Opin Immunol. 2003;15:417-421.
12. Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 2001;98:194-200.
13. Rieux-Laucat F, Fisher A, Le Deist F. Cell-death signalling and human disease. Curr Opin Immunol. 2003;15:325-331.
14. Jackson CE, Fischer RE, Hsu AP, et al. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet. 1999;64:1002-1014.
15. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz SD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 1996;98:1107-1113.
16. Wang J, Zheng L, Lobito A, et al. Inherited human caspase-10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 1999;98:47-58.
17. Chun HJ, Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase 8 mutations lead to human immunodeficiency. Nature. 2002;419:395-399.
18. van der Werff ten Bosch J, Otten J, Thielemans K. Autoimmune lymphoproliferative syndrome type III: an indefinite disorder. Leuk Lymphoma. 2001;41:55-65.
19. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409-1418.
20. Martinez-Lorenzo MJ, Alava MA, Gamen S, et al. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol. 1998;28:2714-2725.
21. Anel A, Buferne M, Boyer C, Schmitt-Verhulst AM, Golstein P. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol. 1994;24:2469-2476.
22. Martin-Fernandez JM, Cabanillas JA, Rivero-Carmena M, et al. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes. J Leukoc Biol. 2005;77:661-668.
23. Martinez-Lorenzo MJ, Anel A, Gamen S, et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol. 1999;163:1274-1281.
24. Monleon I, Martinez-Lorenzo MJ, Monteagudo L, et al. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol. 2001;167:6736-6744.
25. Allende LM, Hernández M, Corell A, et al. A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/lymphocyte function-associated antigen-1 functional association in humans. Immunology. 2000;99:440-450.
26. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
27. Bosque A, Pardo J, Martinez-Lorenzo MJ, et al. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL and c- FLIP, Bim or Bcl-x isoform expression. J Leukoc Biol. 2005;77:568-578.
28. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature. 1995;373:438-441.
29. Wu J, Metz C, Xu X, et al. A novel polymorphic CAAT/enhancer-binding protein β element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American lupus erythematous patients. J Immunol. 2003;170:132-138.
30. Lenardo M, Chan FKM, Hornung F, et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol. 1999;17:221-253.
31. Peitsch MC, Tschopp J. Comparative molecular modelling of the Fas-Ligand and other members of the TNF family. Mol Immunol. 1995;32:761-772.
32. Orlinick JR, Elkon KB, Chao MV. Separate domains of the human Fas ligand dictate selfassociation and receptor binding. J Biol Chem. 1997;272:32221-32229.
33. Mysler E, Bini P, Drappa J, et al. The apoptosis-1/Fas protein in human lupus erythematosus. J Clin Invest. 1994;93:1029-1034.
34. National Center for Biotechnology Information. OMIM: online Mendelian inheritance in man. http://www.ncbi.nlm.nih.gov/omim. Accessed September 1, 2005.